Schizophrenia/Psychosis

Different flowers need different levels of light, water, and shade. What would it mean to treat patients with a similar amount of care?

At the Annual Psychiatric Times World CME Conference, an all-star lineup of presenters will share their latest research. Check out this preview of the full agenda.

Mental illnesses are too often shrouded in secrecy and shame. What would happen if we spoke out about the cases we knew best—the ones in our own families?

Secondary causes for psychosis are more common in older adults (65 years or older) than in younger patients. Here are 6 possible culprits.

The one-of-its-kind 6-month paliperidone palmitate treatment for schizophrenia has received FDA approval.

What can philosophy learn from madness?

The emergency department is a primary care location for patients with schizophrenia. Here’s how to manage schizophrenia in this particular setting in an informed and caring manner.

Most psychotic disorders appear in adolescents or young adults, but some also occur during later life. Here's how to recognize and treat them.

A new digital therapeutic helps patients with psychosis to slow down and manage their fears.

Artificial intelligence and natural language processing provide powerful new tools to measure thought disorder and negative symptoms in schizophrenia.

How is “disease” defined? A popular criticism of psychiatry gets debunked.

A growing body of scientific literature makes the case.

An extended release, ultra-long acting antipsychotic takes another step forward in the approval process.

New research may help better understand psychosis etiology as well as provide potential biomarkers for psychosis.

Cannabis has been heralded as a treatment for many conditions, but what about its psychiatric risks?

A recent study dives into the data.

Simple but powerful strategies for drawing on patients’ existing character strengths and long-term goals.

Being unable to experience pleasure and having difficulty imagining future enjoyment are different problems—and may require different treatments.

This combination treatment of olanzapine and samidorphan caused significantly less weight gain in patients with schizophrenia and bipolar I disorder.

Sleep problems are understudied, underdiagnosed, and undertreated.

What do we know about TD? What is on the horizon? Take the quiz to learn more.

There is debate whether schizoaffective disorder is a separate illness or is part of the continuum of schizophrenia and mood disorder spectrum.

In this conversation, a former APA president discusses mystical and meditative experiences, reconciling psychoanalysis and neuroscience, and tensions surrounding the medical model.

This treatment for agitation associated with schizophrenia and bipolar disorder is moving up the FDA ladder…